Ulcerative colitis starts with a breakdown in the protective lining of the colon, followed by an immune response that spirals out of control. Rather than a single dramatic event, the disease typically builds gradually. Most people notice symptoms developing over weeks or months before they seek medical attention.
What’s happening beneath the surface is a chain reaction involving your gut’s protective mucus layer, the bacteria living in your colon, and an immune system that loses the ability to distinguish between harmful invaders and your own tissue.
The Mucus Barrier Breaks Down First
Your colon is lined with a thick layer of mucus that acts as a physical wall between the trillions of bacteria in your gut and the delicate cells of your intestinal lining. In ulcerative colitis, this barrier weakens before any visible inflammation appears. A study published in Gut found that the two main structural proteins of this mucus layer are reduced before inflammation even begins, meaning the barrier is already compromised by the time symptoms show up.
Specialized cells called sentinel goblet cells are responsible for detecting bacteria that get too close and responding with a burst of protective mucus. In active ulcerative colitis, the number of these sentinel cells drops significantly, and the ones that remain lose their ability to mount a proper response to bacterial threats. Essentially, the colon’s early warning system fails.
Part of what sustains this mucus layer is bicarbonate, a chemical that helps mucus proteins form their protective network. About 30% of ulcerative colitis patients studied had abnormally penetrable mucus, and those patients showed reduced levels of a specific transport protein responsible for delivering bicarbonate to the mucus layer. Without enough bicarbonate, the mucus can’t maintain its structure, and bacteria gain access to cells they were never supposed to touch.
The Immune System Overreacts
Once bacteria breach the weakened mucus barrier and reach the intestinal lining, the immune system responds. In a healthy colon, this response is measured and temporary. In ulcerative colitis, it escalates and never fully shuts off.
Two types of immune cells drive most of the damage. The first releases chemicals that directly activate intestinal cells and attract waves of additional immune cells to the area, creating a self-reinforcing cycle of inflammation. The second type produces signals that break down the tight junctions holding intestinal cells together, the molecular glue that keeps the lining intact. As these junctions weaken, even more bacteria slip through, which triggers even more immune activity.
The inflammatory signals also cause intestinal cells to die at an accelerated rate. One key signal activates a pathway that causes neighboring cells to produce still more inflammatory chemicals, recruiting yet another round of immune cells called neutrophils. This creates a feedback loop: inflammation damages the lining, the damaged lining lets more bacteria through, and the immune system responds with more inflammation. Breaking this cycle is essentially what treatment aims to do.
What Triggers the Process
No single cause has been identified. Instead, ulcerative colitis appears to require a combination of genetic vulnerability, changes in gut bacteria, and environmental exposures that collectively push the system past a tipping point.
Genetics
Variations in dozens of genes have been linked to ulcerative colitis, though no single gene is responsible. The most studied involve genes related to immune regulation and the intestinal barrier. Having a first-degree relative with the disease increases your risk, but most people who develop ulcerative colitis have no family history at all.
Shifts in Gut Bacteria
People with ulcerative colitis consistently show a loss of bacterial diversity in the colon, particularly a depletion of oxygen-sensitive bacteria that produce butyrate, a fatty acid that feeds and maintains the intestinal lining. At the same time, oxygen-tolerant bacteria and species normally found in the mouth become more abundant in the colon. A 2025 systematic review in Gastroenterology confirmed that these shifts, specifically the loss of anaerobic bacteria and the gain of oral-associated bacteria, are core features present at the onset of both ulcerative colitis and Crohn’s disease.
Environmental Factors
Psychological stress doesn’t cause ulcerative colitis, but it can play a role in triggering flares once the disease exists. Research from UCLA found that ulcerative colitis patients with high levels of stress and anxiety were significantly more likely to experience flares. Animal studies have shown that early life stress reduces gut bacterial diversity and specifically depletes butyrate-producing bacteria, the same pattern seen in human IBD.
Diet also appears to matter. Preliminary research suggests that red meat, food additives, and preservatives may be harmful, while antioxidant-rich fruits and vegetables, resistant starch from grains and legumes, and fatty fish like salmon may help reduce symptoms in some patients. These dietary factors likely influence the disease through their effects on gut bacteria rather than through direct damage to the colon.
How Symptoms Typically Appear
Ulcerative colitis symptoms develop over time rather than striking all at once. The most common early signs are diarrhea (often with blood, mucus, or pus), abdominal cramping, rectal pain, and an urgent need to use the bathroom. Some people also experience fatigue, weight loss, or fever. Many people initially attribute bloody stool to hemorrhoids or a mild stomach bug, which can delay diagnosis.
The disease almost always starts in the rectum and can extend upward through the colon. At diagnosis, roughly 80% of adults have disease limited to the left side of the colon or less. Only about 20% have inflammation spanning the entire colon at the time they’re first diagnosed.
How It Progresses After Onset
Ulcerative colitis is not static. Of the patients who start with limited disease, up to half will experience the inflammation spreading further up the colon over time. The risk increases steadily: approximately 15% see progression within 5 years, 30% within 10 years, and 50% after 25 years. One finding that may eventually help predict who progresses: patients who have microscopic inflammation beyond the area that looks inflamed during a colonoscopy are more likely to experience this upward spread.
Diagnosis requires a colonoscopy with tissue biopsies from the colon lining. Blood tests can check for anemia and markers of inflammation, and stool tests can detect immune cells or proteins that suggest active disease while ruling out infections. Sometimes a shorter exam called a flexible sigmoidoscopy is done instead if the colon is too severely inflamed for a full colonoscopy.
Who Gets It
Ulcerative colitis affects men and women at roughly equal rates. CDC data from 2015 showed a prevalence of 1.1% in men and 1.4% in women, a difference that was not statistically significant. The condition can begin at any age, though the prevalence increases with age, from 0.5% in adults aged 18 to 24 up to 1.7% in those 65 and older. Geographically, rates are fairly consistent across U.S. regions, though adults living in suburban areas had a slightly higher prevalence (1.4%) than those in urban centers (1.0%).